Brief: Kuros Biosciences To Hold EGM To Seek Approval for Share Capital Increase

Kuros Biosciences AG

11/09/2020 06:17

Sept 11 (Reuters) - KUROS BIOSCIENCES AG  KURN.S :
    * IT WILL HOLD AN EXTRAORDINARY GENERAL MEETING (EGM) OF
SHAREHOLDERS TO SEEK APPROVAL TO INCREASE COMPANY'S ORDINARY
SHARE CAPITAL
    * SHARE CAPITAL INCREASE AIMS AT RAISING UP TO AROUND CHF 15
MILLION BY ISSUING UP TO 9 MILLION NEWLY CREATED ORDINARY SHARES
    * COMPANY INTENDS TO USE NET PROCEEDS TO ACCELERATE AND
ADVANCE
COMMERCIAL ROLL-OUT OF MAGNETOS, WHICH BASED ON CURRENT
PERFORMANCE IS EXPECTED TO BECOME CASH FLOW POSITIVE FOR COMPANY
BY END OF 2022
    * PROCEEDS SHALL ALSO ALLOW FOR FURTHER CLINICAL DEVELOPMENT
OF
FIBRIN-PTH, WHICH TARGETS A SUBSTANTIAL CLINICAL NEED IN
ORTHOPEDICS AND NEUROSURGERY

Source text for Eikon:  ID:nTENcayi3a 
Further company coverage:  KURN.S 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))